Cancer Types | Liver Cancer - National Foundation for Cancer Research

Liver Cancer

Liver Cancer

About Liver Cancer

Liver cancer is the fifth most common cancer in men and the ninth most common cancer in women worldwide. The incidence rate of liver cancer is larger in developing countries. In the U.S., the rate increases in women by 2% per year and for men, the rate has stabilized.

Breast Cancer Ribbon

Prevention Tips

  • Get the hepatitis B (HBV) vaccine
  • Screening and testing for chronic HBV and HCV infection
  • Get treatment for chronic hepatitis B in infection
  • Reduce the exposure to aflatoxin B1
  • Limit alcohol usage
  • Limit tobacco usage
  • Healthy lifestyle
  • Limit exposure to cancer-causing chemicals
  • Treat diseases that increase liver cancer risk
Resource: Can Liver Cancer Be Prevented? | American Cancer Society

Liver Cancer Signs & Symptoms

A symptom is a change in the body that a person can see and/or feel. A sign is a change that the doctor sees during an examination or on a laboratory test result. If you have any of the symptoms below, it does not mean you have cancer but you should see your doctor or health care professional so that the cause can be found and treated, if needed.

  • Weight loss (without trying)
  • Loss of appetite
  • Feeling very full after a small meal
  • Nausea or vomiting
  • An enlarged liver, felt as fullness under the ribs on the right side
  • An enlarged spleen, felt as fullness under the ribs on the left side
  • Pain in the abdomen (belly) or near the right shoulder blade
  • Swelling or fluid build-up in the abdomen (belly)
  • Itching
  • Yellowing of the skin and eyes (jaundice)
Source: American Cancer Society 2024

Risk Factors for Liver Cancer

  • Sex – more common in men
  • Race/Ethnicity – Asian Americans and Pacific Islanders have the highest rates of liver cancer
  • Chronic viral hepatitis – hepatitis B (HBV) or hepatitis C (HCV)
  • Cirrhosis
    • Non-alcoholic fatty liver disease
    • Primary biliary cirrhosis
  • Inherited metabolic disease
  • Heavy alcohol usage
  • Tobacco usage
  • Obesity
  • Type 2 diabetes
  • Certain rare diseases, such as
    • Tyrosinemia
    • Alpha1-antitrypsin deficiency
    • Porphyria cutanea tarda
    • Glycogen storage diseases
    • Wilson disease
  • Aflatoxins
  • Vinyl chloride and thorium dioxide (Thorotrast)
  • Anabolic steroid
  • Nonalcoholic steatohepatitis (NASH) – A condition that can cause cirrhosis that may lead to liver cancer
Resource:
Liver Cancer Risk Factors | Risk of Liver Cancer | American Cancer Society
Liver Cancer Causes, Risk Factors, and Prevention – NCI

Liver Cancer Key Facts

  • An estimated 42,340 new cases of liver cancer will be diagnosed in the U.S. in 2026, with 30,980 deaths expected to result from the diagnosis.
  • For the 42% of people who are diagnosed with liver cancer at localized-stage, the five-year survival rate is 38%.
  • For those people diagnosed with liver cancer at regional stages, the five-year survival rate drops to 22%.
  • Liver cancer is approximately three times more likely to occur in men than in women.
  • The liver is a common place where cancer spreads. Colorectal, breast, esophageal, stomach, pancreatic, kidney, lung and melanoma skin cancers are the most common sources of cancer that metastasize to the liver.
  • Approximately 75% of liver cancer cases in the US could potentially be prevented through elimination of risk factors, the most important including excess body weight; type 2 diabetes; infection with hepatitis B virus (HBV) and/or hepatitis C (HCV), heavy alcohol consumption and tobacco smoking.

Source: American Cancer Society’s Cancer Facts & Figures 2024 and GLOBOCAN, 2020

What NFCR is doing to address Liver Cancer

The NFCR-Supported and Past-Supported Researchers have programs that will prevent, detect and improve outcomes for liver cancer patients.

Select a research below to learn more about their specific work.

Yung-Chi Cheng, Ph.D.
Yale University

Ronald A. DePinho, M.D.
University of Texas MD Anderson Cancer Center

Paul Fisher, M.Ph., Ph.D.
Virginia Commonwealth University School of Medicine

Webster K. Cavenee, Ph.D.
Ludwig Institute for Cancer Research

Liver Cancer Awareness Month is recognized in October.